Capacity-building is key to sustainable development efforts. For all the right reasons, over the past decades it has also enjoyed considerable attention in the field of health and development. However, perspectives on what capacity-building means, what it intends to achieve and which strategies are most effective differ, depending on the context and the perspectives of a variety of stakeholders. This Webinar aims to contribute to a reflection on pharmaceutical capacity building. One of the Ecumenical Pharmaceutical Network’s core mandate is to fill the gaps in our member institutions by ensuring that they have qualified and skilled pharmaceutical staff. EPN has 30 Church Health Associations with over 20,000 health care facilities all over sub-Saharan Africa. The findings of an EPN Human Resources (HR) Mapping Survey1 that was carried out between 2008 and 2010 revealed a shortage of trained pharmaceutical staff in many Sub-Saharan African countries. As part of efforts towards the professionalization of pharmaceutical services in our member institutions, the Essentials of Pharmaceutical Practice (EPP) and the Ecumenical Scholarship Program (ESP) were developed in 2010. Our Capacity Building Program aims to respond to the needs of human resource gap in pharmaceutical services, especially in Faith-Based Organizations by training pharmacy personnel so as to provide reasonable level of professional and quality pharmaceutical services. The course is customized to fit the settings of faith-based hospitals and health facilities in Low and Middle-Income countries (LMICs) and capacitate the staff in pharmaceutical management and service provision. Due to its modular structure, it can easily be shortened and adjusted according to arising needs. This has led to improvements in the facilities of the member organizations that have participated in the training. Under this program, EPN partners with its various member organizations to carry out training with the ultimate goal of improving patient outcomes through better access to and use of medicines. Since the scholarship program was developed, more than 80 beneficiaries from 20 countries were offered both Diploma and Degree scholarships from 2011-2021. Close to 500 beneficiaries have undertaken the Essentials of Pharmaceutical Practice course. One of the main findings of a recent evaluation was to prioritize activities to better meet the needs of EPN members. Therefore, the main goal of the 2021-2025 strategy is to improve how well EPN helps members improve the quality of pharmaceutical services they provide. EPN will first assist the bottom 25% of members and their facilities most in need in terms of pharmaceutical performance. A mapping of member needs which has commenced, will allow for an assessment of the current needs and capacity of member Christian Health Associations (CHAs) and if possible, of the Christian Health Institutions (CHIs) to find out who are in most needs. The mapping will gather the three most pressing needs and the total number of hospitals and pharmacists of each CHA and scholarships/ EPP trainings received by each EPN member. This information will help plan the next round of scholarships and allocate them to those in most need and prioritize the activities of the five programs over the next 5 years. MEDS Experience Capacity Building - Agnes Njue, Capacity Building Manager, MEDS EPN renewed capacity building approach - Richard Neci (Executive Director, EPN) Capacity building of pharmaceutical staff in church Health institutions: gaps and way forward - Prof. Richard Laing’, Global Health Expert, Boston University, USA Protected: Capacity building of pharmaceutical staff in church Health institutions: gaps and way forward – May 2021
Description
Post-Webinar: Presentations and Resources
Presentations
Recording
Referenced resources
La pandémie COVID-19 a changé la prestation des services pharmaceutiques dans le monde. Les services et produits pharmaceutiques jouent un rôle vital en Santé Publique dans l’offre des soins de santé efficaces et prévenir les maladies. En Afrique subsaharienne et dans le monde entier, les personnels de la santé et les acteurs de la sphère pharmaceutique répondent de différentes manières aux défis de la pandémie, pour maintenir les capacités de fabrication et l'accès aux matières premières. Ils abordent les problèmes de gestion d'une chaîne d'approvisionnement impactée par la pandémie, les effets des réglementations, les opportunités émergentes, la contribution à la disponibilité du vaccin COVID-19, le rôle de communication et de partage d'informations dans le contrôle de la pandémie et son effet sur l'accès à des médicaments et produits de qualité, la prévention et gestion des infections
La gestion des différentes fonctions de la chaîne d'approvisionnement exige une bonne capacité de planification, des systèmes de gestion des données et une stratégie de partage d'informations pour prendre des décisions éclairées. La communication interprofessionnelle, les compétences en leadership, la gestion des relations avec les partenaires, les clients et les fournisseurs sont essentielles pour maintenir des services pharmaceutiques et produits médicaux de qualité.
Une gestion efficace des données conduit à une meilleure prise de décision; et la communication est la clé dans le partage d'informations, la gestion des données et les relations interprofessionnelles. Chaque fois que les informations avec lesquelles nous devons travailler dépassent ou ne correspondent pas à nos besoins et à notre capacité de traitement, il en résulte une communication inefficace.
Dans notre rôle de renforcement des systèmes pharmaceutiques, l'adoption de meilleures pratiques inclusives en matière de communication, de partage d'informations et de gestion des données entre les principales parties prenantes et avec les personnes que nous servons est susceptible d'avoir un impact sur l’offre de services pharmaceutiques de bonne qualité et la disponibilité du vaccin COVID-19.
La série de Webinaires de 2 jours vise à rassembler les membres du réseau EPN, les partenaires et les acteurs de santé pour discuter de la manière d'améliorer la l’offre de services et produits pharmaceutiques de bonne qualité dans le contexte du défi mondial de COVID-19.
Jour 1: Lundi, 22 Février 2021
Jour 2: Mardi, 23 février 2021